AIM ImmunoTech Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About AIM ImmunoTech Inc
AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies. Its flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) molecule being developed for globally important cancers, viral diseases, and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe Chronic Fatigue Syndrome (CFS).
/ 
Frequently asked questions
To buy AIM ImmunoTech Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for AIM ImmunoTech Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for AIM ImmunoTech Inc is AIM:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
AIM ImmunoTech Inc has its primary listing on NYSE American. You can trade AIM ImmunoTech Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, AIM ImmunoTech Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include AIM ImmunoTech Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like AIM ImmunoTech Inc.